2 news items
Morgan Stanley Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $596
IDXX
14 May 24
Morgan Stanley analyst Erin Wright maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and lowers the price target from $620 to $596.
Barclays Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $570
IDXX
2 May 24
Barclays analyst Balaji Prasad maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and lowers the price target from $655 to $570.
- Prev
- 1
- Next